ORAGENICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
ORAGENICS, INC. (OGEN) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $5.17 per share as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $5.17.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $5.17.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $5.54.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $156.72.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $5.17 10-Q · filed 2026-08-13 |
| 2026-03-31 | $5.17 10-Q · filed 2026-05-08 |
| 2025-12-31 | $5.54 10-K · filed 2026-03-16 |
| 2025-09-30 | $156.72 10-Q · filed 2025-11-07 |
| 2025-06-30 | $164.00 10-Q · filed 2025-08-08 |
| 2025-03-31 | $5.08 10-Q · filed 2025-05-09 |
| 2024-12-31 | $4.97 10-K · filed 2025-03-14 |
| 2024-09-30 | $5.03 10-Q · filed 2024-11-13 |
| 2024-06-30 | $22.55 10-Q · filed 2024-08-09 |
| 2024-03-31 | $25.36 10-Q · filed 2024-05-15 |
| 2023-12-31 | $25.02 10-K · filed 2024-03-29 |
| 2022-12-31 | $45.54 10-K · filed 2023-04-17 |
| 2022-09-30 | $0.77 10-Q/A · filed 2023-04-14 |
| 2022-06-30 | $0.89 10-Q/A · filed 2023-04-14 |
| 2022-03-31 | $0.96 10-Q/A · filed 2023-04-14 |
| 2021-12-31 | $0.97 10-K/A · filed 2022-07-29 |
| 2021-09-30 | $1.02 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.00 10-Q · filed 2021-08-16 |
| 2021-03-31 | $0.98 10-Q · filed 2021-05-03 |
| 2020-12-31 | $1.06 10-K · filed 2021-03-01 |
| 2020-09-30 | $1.06 10-Q · filed 2020-11-10 |
| 2020-06-30 | $1.08 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.12 10-Q · filed 2020-05-15 |
| 2019-12-31 | $1.77 10-K · filed 2020-03-04 |
| 2018-12-31 | $2.57 10-K · filed 2019-03-29 |
| 2017-12-31 | $12.10 10-K · filed 2018-02-16 |
| 2016-12-31 | $1.75 10-K · filed 2017-02-27 |
| 2015-12-31 | $2.89 10-K · filed 2016-03-30 |
| 2014-12-31 | $5.02 10-K · filed 2015-02-27 |
| 2013-12-31 | $5.47 10-K · filed 2014-02-28 |
| 2012-12-31 | $5.35 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |